(Updated - September 1, 2026 7:02 AM EDT)

Canaccord analyst Edward Nash initiates coverage on Aclaris Therapeutis (NASDAQ: ACRS) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE